| Concert Pharmaceuticals Announces CTP-499 Data Presentations at the American ... - Benzinga (press release) |
|
|
Benzinga (press release) Concert Pharmaceuticals, Inc. today announced that three abstracts relating to CTP-499, its clinical candidate for the potential treatment of diabetic nephropathy, have been accepted for poster presentations at the American Society of Nephrology's |